文献速递乳房整形与再造显微修复重建

显微乳房再造的演变与实践模式:欧洲多中心研究

Evolution and practice pattern in microsurgical breast reconstruction-A European multicenter study.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2025-05-14

该回顾性多中心研究纳入2010至2019年6个欧洲医学中心共4025例显微乳房再造(3344例患者),按腹部皮瓣与替代皮瓣分组比较。结果显示显微乳房再造每年显著增长3.7%(p=0.019),替代皮瓣使用每年增长12.6%(p<0.001),年龄、BMI、放疗、再造侧别、乳房切除类型及既往假体失败是皮瓣选择的显著预测因素。

要点

  • 显微乳房再造及替代皮瓣使用呈持续增长趋势。
  • DIEP、TMG和MS-TRAM皮瓣使用占比超过90%。
  • 年龄、BMI、放疗及既往假体失败影响皮瓣选择。

核心结论

  • 自2010年以来显微乳房再造显著增加,并持续向替代皮瓣演变。
  • 手术与辅助乳腺癌治疗影响未来显微乳房再造的选项。
  • 定制化方案可使每位患者在独特情况下选择自然乳房再造。

研究设计与样本

  • 回顾性多中心研究,纳入6个欧洲医学中心2010年1月至2019年12月所有显微乳房再造患者。
  • 共3344例患者、4025例显微乳房再造,按腹部皮瓣组与替代皮瓣组分组比较。
  • 采用线性回归分析演变趋势,多重混合效应logistic回归识别皮瓣选择预测因素。

主要发现

  • 腹部皮瓣组2891例患者(86%)共3440个皮瓣,替代皮瓣组453例患者(14%)共585个皮瓣。
  • 显微乳房再造每年显著增长3.7%(p=0.019)。
  • 替代皮瓣使用每年显著增长12.6%(p<0.001)。
  • DIEP、TMG和MS-TRAM皮瓣在超过90%的病例中使用。
  • 两组在特征、围手术期和术后参数上差异显著。

关键数值与推荐

  • 年龄、体重指数、放疗、乳房再造侧别、乳房切除类型及既往假体失败是皮瓣选择的显著预测因素。

临床怎么用

  • 临床决策应综合年龄、BMI、放疗史、再造侧别、乳房切除类型及既往假体失败等因素选择皮瓣。
  • 替代皮瓣使用增长提示需掌握DIEP、TMG和MS-TRAM等多种显微再造技术。
  • 定制化概念有助于在患者独特情况下实现自然乳房再造。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study investigated the evolution and practice pattern in microsurgical breast reconstruction. METHODS: A retrospective multicenter study was conducted including all patients who underwent microsurgical breast reconstruction in 6 European medical centers (January 2010 to December 2019). Patients were grouped according to the flap in the abdominal or alternative group. The patient and outcome data were merged for comparative analysis. Linear regression analysis was used to objectify the evolution in microsurgical breast reconstruction. A multiple mixed effects logistic regression model was applied to identify the predictors for the flap choice. RESULTS: A total of 4025 microsurgical breast reconstructions were performed in 3344 patients. Among them, 2891 (86%) patients with 3440 flaps were included in the abdominal group and 453 (14%) patients with 585 flaps were included in the alternative group. There was a significant increase (3.7% per year, p = 0.019) in microsurgical breast reconstruction and alternative flaps usage (12.6% per year, p < 0.001). The deep inferior epigastric perforator, transverse musculocutaneous gracilis, and muscle-sparing - transverse rectus abdominis muscle flap were used in >90% cases. The groups differed significantly in characteristics, perioperative, and postoperative parameters. Age, body mass index, radiotherapy, breast reconstruction laterality, the type of mastectomy, and previous implant failure were significant predictors for the flap choice. CONCLUSIONS: This multicenter study outlined a significant increase in microsurgical breast reconstruction and continuous evolution to alternative flaps since 2010. It objectivized the relation of surgical and adjuvant breast cancer therapy on future options in microsurgical breast reconstructions and showed that customized concepts allow each patient in her unique situation to choose natural breast reconstruction.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Siegwart LC, Grünherz L, Weitgasser L, et al. Evolution and practice pattern in microsurgical breast reconstruction-A European multicenter study. J Plast Reconstr Aesthet Surg. 2025. PMID: 40449322. doi:10.1016/j.bjps.2025.05.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。